LINCOMYCIN
Generic: LINCOMYCIN
Armas Pharmaceuticals Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
LINCOMYCIN HYDROCHLORIDEActive Substance
2021-11-08Original Approval
LINCOMYCIN is FDA application ANDA215082, sponsored by MICRO LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
33 reports
2
DRUG HYPERSENSITIVITY
24 reports
3
DIARRHOEA
14 reports
4
CELLULITIS
11 reports
5
OFF LABEL USE
11 reports
6
PYREXIA
10 reports
7
STEVENS-JOHNSON SYNDROME
10 reports
8
LIVER INJURY
9 reports
9
RASH
9 reports
10
CONDITION AGGRAVATED
8 reports